1.48
1.37%
+0.02
Handel nachbörslich:
1.48
Akari Therapeutics Plc ADR Aktie (AKTX) Neueste Nachrichten
Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
GlobeNewswire Inc.
Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
GlobeNewswire Inc.
Dialing Up Nights Out: Heineken® & Bodega Launch the No-Frills 'Boring Phone' | GlobeNewswire by notified - NTB Kommunikasjon
NTB Kommunikasjon
Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights
GlobeNewswire Inc.
Akari Therapeutics to Present at Biotech Showcase 2024
GlobeNewswire Inc.
Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors
GlobeNewswire Inc.
Kapitalisierung:
|
Volumen (24h):